1.
Addressing Metabolic Dysfunction‑Associated Steatotic Liver Disease (MASLD) in Endocrinology Settings in Canada: From Prevalence to Patient-Centered Management. Can Diabetes Endocrinol Today. 2025;3(s01):2–8. doi:10.58931/cdet.2025.3s0144